Hypersensitivity reactions, including anaphylaxis, anaphylactoid reactions, angioedema, rash, and urticaria, have been reported postmarketing with use of semaglutide
The legal position in Australia is restrictive, the safety risks are real when sourcing is unregulated, and the foundations of knee recovery remain far better established than any peptide protocol
Other risk factors include age over 50 (reduced gastric acid impairs absorption), proton pump inhibitor use, prior gastric surgery, and Type 1 diabetes
Reduced hunger, improved blood sugar levels, and enhanced weight loss
Important Notice: This product is supplied for research purposes only
Serum B12 above 300 pg/mL is often interpreted as normal (6) Serum B12 levels between 200 and 300 pg/mL are considered borderline (in which case further enzymatic testing may be helpful for diagnosis) (6) Enzymatic testing: serum levels of MMA and homocysteine should both be elevated if B12 deficiency is present